EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 76 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,691,603 | -7.5% | 211,715 | +0.7% | 0.00% | – |
| Q2 2023 | $1,829,645 | +200.7% | 210,304 | +1.6% | 0.00% | – |
| Q1 2023 | $608,383 | -14.7% | 206,933 | +1.5% | 0.00% | – |
| Q4 2022 | $713,314 | -56.9% | 203,804 | -2.7% | 0.00% | – |
| Q3 2022 | $1,656,000 | -1.7% | 209,415 | -2.2% | 0.00% | – |
| Q2 2022 | $1,685,000 | -33.6% | 214,049 | +2.5% | 0.00% | – |
| Q1 2022 | $2,538,000 | +11.5% | 208,845 | +12.3% | 0.00% | – |
| Q4 2021 | $2,277,000 | +13.3% | 186,027 | -3.5% | 0.00% | – |
| Q3 2021 | $2,009,000 | +220.4% | 192,828 | +176.3% | 0.00% | – |
| Q2 2021 | $627,000 | +35.4% | 69,783 | +53.3% | 0.00% | – |
| Q1 2021 | $463,000 | +372.4% | 45,521 | +205.0% | 0.00% | – |
| Q4 2020 | $98,000 | – | 14,925 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,490,921 | $27,892,459 | 24.59% |
| ACUTA CAPITAL PARTNERS, LLC | 300,128 | $2,398,023 | 1.61% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,492,147 | $27,902,255 | 1.51% |
| Cormorant Asset Management, LP | 3,200,000 | $25,568,000 | 1.49% |
| Samsara BioCapital, LLC | 432,000 | $3,451,680 | 1.06% |
| Ghost Tree Capital, LLC | 325,000 | $2,596,750 | 0.85% |
| RA Capital Management | 3,370,506 | $26,930,343 | 0.53% |
| Ikarian Capital, LLC | 4,487 | $3,585,113 | 0.43% |
| Affinity Asset Advisors, LLC | 155,000 | $1,238,450 | 0.35% |
| SECTORAL ASSET MANAGEMENT INC | 176,080 | $1,406,879 | 0.27% |